Abstract
AbstractSince the first transplant in 1957 and hematopoietic stem cell transplantation (HSCT) is the curative modality for numerous hematological disorders. Nevertheless, it is not available for all patients. Besides unavailability of matched donors a lot of factors could hinder HSCT in a resource limited setting, as financial and administrative factors. In our daily practice we noticed other factors that hinder HSCT in our center, the common myths and misconceptions about HSCT and donation. This quasi-experimental study assessed, for the first time, common myths and misconceptions about HSCT among 218 medical and nursing students before and after an interventional educational program. The study tool was an investigators' developed self-administered questionnaire. Participants' male to female ratio was 1:2.5, and FAS was middle in 52.7%. Pretest high myths scores were reported in 53.4% and 90% of medical and nursing students that was reduced to 0% and 4% post-test, respectively. Pretest, 26.3% and 7% of medical and nursing students welling to donate HSC, that increased to 66% and 39% post-test, respectively. Rural residency, low and middle FAS associated with higher myths scores. Myths score is an independent effector of willingness to donate HSC among participants. In conclusion medical/nursing students had significant myths and misconceptions about HSCT that was corrected with the educational program. Thus, wide based educational programs about HSCT are mandatory to correct myths and augment HSC donation.www.clinicaltrrial.gov: clinical trial ID NCT05151406.
Publisher
Springer Science and Business Media LLC
Reference24 articles.
1. Kanate AS, Majhail NS, Savani BN, Bredeson C, Champlin RE, Crawford S, Hamadani M (2020) Indications for hematopoietic cell transplantation and immune effector cell therapy: guidelines from the American Society for Transplantation and Cellular Therapy. Biol Blood Marrow Transpl 26(7):1247–1256
2. Thomas ED, Lochte HL Jr, Lu WC, Ferrebee JW (1957) Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. N Engl J Med 257(11):491–496
3. Burt RK, Loh Y, Pearce W, Beohar N, Barr WG, Craig R et al (2008) Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases. JAMA 299(8):925–936
4. Alexander T, Arnold R, Hiepe F, Radbruch A (2016) Resetting the immune system with immunoablation and autologous hematopoietic stem cell transplantation in autoimmune diseases. Clin Exp Rheumatol. 34(4 Suppl 98):53–57
5. Matsumoto MM, Dajani R, Matthews KRW (2015) Cord Blood banking in the arab world: current status and future developments. Biol Blood Marrow Transpl 21(7):1188–1194